Glucose Health, Inc. Income Statement
GLUC|5 years of annual SEC 10-K data (FY2011-FY2016)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$313,229
FY2016
Gross Profit
$19,167
6.1% gross margin
Operating Income
-$86,647
FY2016
Net Income
-$410,443
FY2016
Glucose Health, Inc. reported $313,229 in revenue and $410,443 in net loss for FY2016. Revenue has grown at a 1018.2% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -169.46 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $313.2K | $4.3K | $2.7K | $224 | - |
| Cost of Revenue | $294.1K | $3.9K | $23.5K | $2.3K | - |
| Gross Profit | $19.2K | $397 | -$20.7K | -$2.1K | - |
| SG&A Expense | $51.8K | $114.8K | $16.3K | $39.5K | $14.7K |
| R&D Expense | - | $48 | $4.0K | - | - |
| Operating Income | -$86.6K | -$156.2K | -$545.2K | -$1.3M | -$888.8K |
| Interest Expense | $323.8K | $120.0K | $109.6K | $168.9K | $10.4K |
| Net Income | -$410.4K | -$266.1K | -$669.4K | -$1.5M | -$899.2K |
| EPS (Basic) | -$0.14 | -$0.99 | -$4.91 | -$0.05 | -$0.03 |
| Shares Outstanding | 2.5M | 1.3M | 377.5K | 10.1M | 19.7M |
| Gross Margin | 6.1% | 9.3% | -756.7% | -933.5% | - |
| Operating Margin | -27.7% | -3655.7% | -19905.7% | -566644.6% | - |
| Profit Margin | -131.0% | -6228.1% | -24439.9% | -651404.5% | - |